162 related articles for article (PubMed ID: 26183121)
1. Forum for debate: Safety of allogeneic blood transfusion alternatives in the surgical/critically ill patient.
Muñoz Gómez M; Bisbe Vives E; Basora Macaya M; García Erce JA; Gómez Luque A; Leal-Noval SR; Colomina MJ; Comin Colet J; Contreras Barbeta E; Cuenca Espiérrez J; Garcia de Lorenzo Y Mateos A; Gomollón García F; Izuel Ramí M; Moral García MV; Montoro Ronsano JB; Páramo Fernández JA; Pereira Saavedra A; Quintana Diaz M; Remacha Sevilla Á; Salinas Argente R; Sánchez Pérez C; Tirado Anglés G; Torrabadella de Reinoso P
Med Intensiva; 2015 Dec; 39(9):552-62. PubMed ID: 26183121
[TBL] [Abstract][Full Text] [Related]
2. [The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].
Alberca I; Asuero MS; Bóveda JL; Carpio N; Contreras E; Fernández-Mondéjar E; Forteza A; García-Erce JA; García de Lorenzo A; Gomar C; Gómez A; Llau JV; López-Fernández MF; Moral V; Muñoz M; Páramo JA; Torrabadella P; Quintana M; Sánchez C
Med Clin (Barc); 2006 Jul; 127 Suppl 1():3-20. PubMed ID: 17020674
[TBL] [Abstract][Full Text] [Related]
3. [Implementation of blood sparing programs in Spain: results of a survey of departments of anesthesiology and resuscitation].
Colomina MJ; Basora Macaya M; Bisbe Vives E
Rev Esp Anestesiol Reanim; 2015 Jun; 62 Suppl 1():3-18. PubMed ID: 26320339
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
5. Anemia and transfusion in critically ill pediatric patients: a review of etiology, management, and outcomes.
Sloniewsky D
Crit Care Clin; 2013 Apr; 29(2):301-17. PubMed ID: 23537677
[TBL] [Abstract][Full Text] [Related]
6. Massive transfusion and trauma patient management: pathophysiological approach to treatment.
Zunini-Fernandez G; Rando-Huluk K; Martínez-Pelayo FJ; Castillo-Trevizo AL
Cir Cir; 2011; 79(5):473-80. PubMed ID: 22385770
[TBL] [Abstract][Full Text] [Related]
7. Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations.
Muñoz M; García-Erce JA; Villar I; Thomas D
Vox Sang; 2009 Jan; 96(1):1-13. PubMed ID: 19121192
[TBL] [Abstract][Full Text] [Related]
8. [Perioperative anemia correction in Patient Blood Management programs: Lights and shadows].
Muñoz Gómez M; Leal Noval SR
Rev Esp Anestesiol Reanim; 2015 Oct; 62(8):421-4. PubMed ID: 25823957
[No Abstract] [Full Text] [Related]
9. Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.
Sniecinski RM; Chen EP; Makadia SS; Kikura M; Bolliger D; Tanaka KA
J Cardiothorac Vasc Anesth; 2010 Dec; 24(6):959-63. PubMed ID: 20430647
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
12. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
[TBL] [Abstract][Full Text] [Related]
13. Society for the advancement of blood management administrative and clinical standards for patient blood management programs. 4th edition (pediatric version).
Goobie SM; Gallagher T; Gross I; Shander A
Paediatr Anaesth; 2019 Mar; 29(3):231-236. PubMed ID: 30609198
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of anemia in Patient Blood Management from an economic perspective].
Bisbe Vives E
Rev Esp Anestesiol Reanim; 2015 Jun; 62 Suppl 1():80-5. PubMed ID: 26320350
[TBL] [Abstract][Full Text] [Related]
15. Antifibrinolytics.
Schmarts
Acta Anaesthesiol Belg; 2003; 54(4):319-22. PubMed ID: 14719353
[No Abstract] [Full Text] [Related]
16. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler JO
Braz J Anesthesiol; 2013 Jan; 63(1):27-35. PubMed ID: 24565088
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic approach to postoperative anemia].
Bisbe Vives E; Moltó L
Rev Esp Anestesiol Reanim; 2015 Jun; 62 Suppl 1():41-4. PubMed ID: 26320343
[TBL] [Abstract][Full Text] [Related]
18. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
[TBL] [Abstract][Full Text] [Related]
19. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty.
Watts CD; Pagnano MW
J Bone Joint Surg Br; 2012 Nov; 94(11 Suppl A):8-10. PubMed ID: 23118371
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyethyl starch and granulocyte transfusions: considerations of utility and toxicity profile for patients and donors.
Ambruso DR
Transfusion; 2015 Apr; 55(4):911-8. PubMed ID: 25315227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
